Fact CheckerSign in

NCT06909968Completed

Identification of Palliative Care Needs and Prognostic Factors of Survival in Tailoring Appropriate Interventions in Advanced Oncological, Renal and Pulmonary Diseases

Source: ClinicalTrials.gov · Last updated 3 Dec 2025

Brief summary (registry, in English)

This is a prospective observational study done on 3 patient populations (cancer, chronic pulmonary and renal disease). All patients will be treated and monitored according to the local clinical practice. No additional procedures/patient visits in comparison with the usual clinical practice are planned for the study.

Status (registry)
Completed
Study type
Observational
Enrollment
178 (actual)
First submitted
20 Mar 2025
Start date
14 Dec 2020
Primary completion date
26 Feb 2025
Lead sponsor
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
NCT number
NCT06909968

What you commit to

  • Study type: Observational
  • Participants enrolled: 178
  • From 14 Dec 2020 to the primary completion date, 26 Feb 2025
  • 5 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

  • Both sex;
  • All ethnic background;
  • Age ≥18 years;
  • Subjects who are, in the opinion of the Investigator, able to understand this study and to cooperate with the study procedures;
  • Written informed consent;
  • Not receiving care from the palliative care service
  • Diagnosis of inoperable locally advanced and/or metastatic non-small cell lung cancer, or gastric cancer or pancreatic adenocarcinoma within the previous eight weeks, any T, any N, M+ or T4 inoperable (neoadjuvant excluded);
  • Life expectancy \>2 months;
  • Diagnosis of chronic obstructive pulmonary disease (COPD) with at least two of these characteristics: age \> 70 years, FEV1 \<30 % predicted, oxygen-therapy dependency, \> 1 admission/year in hospital for COPD exacerbated, congestive heart failure and/or other comorbidity, weight loss/cachexia, reduced functional autonomy, increase dependence.
  • or idiopathic pulmonary fibrosis (IPF) diagnosis with at least two of these characteristics: age \> 70 years, histological pattern "UIP" (if known), dependence on oxygen-therapy, radiological aspect of "Honeycomb" to the HRTC of the thorax, reduced functional autonomy, increased dependence.
  • \- Diagnosis advanced chronic renal failure with at least two of these characteristics: age \> 75 years, advanced malignancy, severe malnutrition, cardiac or pulmonary pathology terminal, Multiple Organ Failure in Intensive Care.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (5)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
U.O. Nefrologia, Dialisi e Trapianto Renale, Policlinico Sant'Orsola
Coordinator of this site? Confirm its status
BolognaItalyUnknown status
Rete Cure Palliative AUSL Bologna
Coordinator of this site? Confirm its status
BolognaItalyUnknown status
U.O. Pneumologia e Terapia Intensiva Respiratoria, Policlinico Sant'Orsola
Coordinator of this site? Confirm its status
BolognaItalyUnknown status
U.O. Nefrologia e Dialisi, Ospedale Morgagni-Pierantoni - Ospedale M. Bufalini
Coordinator of this site? Confirm its status
ForlìItalyUnknown status
IRST IRCCS UO Cure Palliative
Coordinator of this site? Confirm its status
MeldolaItalyUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.